...
首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >Investigation of the absorbed and metabolized components of Danshen from Fuzheng Huayu recipe and study on the anti-hepatic fibrosis effects of these components
【24h】

Investigation of the absorbed and metabolized components of Danshen from Fuzheng Huayu recipe and study on the anti-hepatic fibrosis effects of these components

机译:扶正化瘀方丹参吸收代谢成分的研究及抗肝纤维化作用的研究

获取原文
获取原文并翻译 | 示例
           

摘要

Ethnopharmacology Fuzheng Huayu recipe (FZHY) was formulated on the basis of Chinese medicine theory in treating liver fibrosis. It has a significant efficacy against liver fibrosis caused by chronic hepatitis B, with the action mechanisms of inhibition of hepatic stellate cell activation, protection of hepatocyte oxidative injury and regulations of hepatic matrix remodeling etc. Aim of the study To identify the absorbed components and metabolites of Danshen in FZHY in rat serum, and find their active components for anti-liver fibrosis. Material and methods A valid high performance liquid chromatography-electrospray ionization ion trap mass spectrometry (HPLC-ESI/MSn) method was established to investigate the absorbed and metabolized compounds of Danshen in FZHY in rat serum after oral administration. Mass spectra were acquired in both negative and positive modes. Otherwise, to evaluate the anti-hepatic fibrosis efficacies of absorbed and metabolized compounds, the LX-2 cell line of hepatic stellate cell (HSC), which was crucial cellular basis of fibrogenesis, was cultured and incubated with absorbed compounds, the cytotoxicity was determined with the cellomics Multiparameter Cytotoxicity Kit 1 by High Content Screening (HCS), the cell proliferation was assayed with EdU-DNA incorporation, and the cell activation was analyzed through α-smooth muscle actin (α-SMA) expression with high content screening technology. Results More than 11 compounds and 2 metabolites from Danshen were identified in the serum after oral administration of FZHY by comparing their mass spectra and retention behavior with reference compounds or literature data. Among these compounds, there were no obvious changes in nuclear morphology, membrane permeability with blow 96 μM of six polar compounds treatment in comparison with control cells, respectively. And the salvianolic acid B (6 μM, 48 μM), caffeic acid (6 μM, 48 μM) and rosmarinic acid (48 μM) could obviously inhibit LX-2 cells proliferation, down-regulate α-SMA expression. Conclusion The results proved that the established method could be applied to analyze the absorbed into blood compounds of Danshen after oral administration FZHY. These absorbed compounds included 11 compounds and 2 metabolites of Danshen. Among them, the salvianolic acid B, caffeic acid and rosmarinic acid were the effective components of FZHY to anti-hepatic fibrosis effects.
机译:在中医药学理论的基础上,制定了民族药理扶正化瘀方(FZHY)。它对慢性乙型肝炎引起的肝纤维化具有显着的功效,具有抑制肝星状细胞活化,保护肝细胞氧化损伤和调节肝基质重塑等作用机制。研究目的确定吸收的成分和代谢产物丹参在FZHY大鼠血清中的含量,并发现其有效成分抗肝纤维化。材料和方法建立了有效的高效液相色谱-电喷雾电离离子阱质谱(HPLC-ESI / MSn)方法,以研究口服后丹参中FZHY在大鼠血清中的吸收和代谢化合物。质谱以负和正两种方式获得。否则,为了评估被吸收和代谢的化合物的抗肝纤维化功效,将肝星状细胞(HSC)的LX-2细胞系作为成纤维的重要细胞基础进行培养,并与吸收的化合物一起孵育,以确定其细胞毒性。通过高含量筛选(HCS)的细胞组学多参数细胞毒性试剂盒1,通过掺入EdU-DNA来检测细胞增殖,并通过高含量筛选技术通过α-平滑肌肌动蛋白(α-SMA)表达来分析细胞活化。结果通过将FZHY的质谱图和保留行为与参考化合物或文献数据进行比较,在口服FZHY后在血清中鉴定出了11种以上的丹参化合物和2种代谢产物。在这些化合物中,与对照细胞相比,六种极性化合物处理的96μM打击下的核形态,膜通透性均无明显变化。丹酚酸B(6μM,48μM),咖啡酸(6μM,48μM)和迷迭香酸(48μM)可以明显抑制LX-2细胞的增殖,下调α-SMA的表达。结论所建立的方法可用于丹参口服液FZHY吸收后血液中化合物的吸收分析。这些吸收的化合物包括丹参的11种化合物和2种代谢产物。其中,丹酚酸B,咖啡酸和迷迭香酸是FZHY抗肝纤维化作用的有效成分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号